Marta Sokolowska
Deputy Center Director, FDA Center for Drug Evaluation and Research
Marta Sokolowska earned a doctoral degree in psychology from McMaster University in Canada. She has held senior clinical and medical leadership roles in the pharmaceutical industry.
She joined the Food and Drug Administration’s Center for Drug Evaluation and Research as an associate director for controlled substances in the Office of the Center Director. She later led the Controlled Substances Program.
She is presently the Deputy Center Director for Substance Use and Behavioral Health in the FDA’s Center for Drug Evaluation and Research, an executive-level position that works on shaping policy and strategies on the use of controlled substances and behavioral health programs.
In the News…
Draft guidance has been issued by the Food and Drug Administration (FDA) on facilitating the development of treatments for substance abuse disorders that relate to stimulants such as cocaine and methamphetamine. The guidance includes development recommendations for clinical trials for drug use.
The FDA’s Substance Use and Behavioral Health Deputy Center Director Marta Sokolowska said, “Currently there is no FDA-approved medication for stimulant use disorder. When finalized, we hope that the guidance will support the development of novel therapies that are critically needed to address treatment gaps.
She added, “The guidance is one of the actions within the agency’s Overdose Prevention Framework, which includes appropriate prescribing of prescription stimulants as well as development of evidence-based treatments for stimulant use disorder.”
A public comment window is open until December 4.
Contact this Leader…
Did you pray for Deputy Director Sokolowska? You can let her know at:
Marta Sokolowska, Ph.D.
Deputy Center Director
Center for Drug Evaluation and Research
Food and Drug Administration
5901-B Ammendale Road
Beltsville, MD 20705-1266
